Search Results

No Results

    Recently Viewed

      Listening...

      Sorry, I don't understand. Please try again
      1. Home/
      2. Media Center/
      3. Press releases /
      4. Corporate

      Corporate

      Corporate
      February 17, 2016

      Johnson & Johnson Issues Call for Innovative Ideas to Reduce HIV Infections in Sub-Saharan Africa

      DREAMS Partners Announce $85 Million Innovation Challenge Focused on Solutions for Adolescent Girls and Young Women
      Learn more
      Corporate
      January 6, 2016

      Johnson & Johnson Health and Wellness Solutions Teams with Plug and Play to Launch Health and Wellness Technology Accelerator

      Announces Call for Wellness Startups for 2016 Accelerator
      Learn more
      Corporate
      January 6, 2016

      Johnson & Johnson Partners with Leading Universities to Advance Women’s Education in Science, Technology, Engineering, Math, Manufacturing and Design (STEM2D)

      Learn more
      Corporate
      December 3, 2015

      Janssen announces collaboration with FIND to transform access to diagnostics and therapeutic solutions for TB and MDR-TB

      Learn more
      Corporate
      November 20, 2015

      Janssen Submits INVOKAMET® XR (Canagliflozin / Metformin Hydrochloride Extended Release) for Approval by the U.S. FDA as an Adjunctive Treatment in Adults with Type 2 Diabetes

      Learn more
      Corporate
      November 6, 2015

      Important Global Data from XARELTO® EXPLORER Cardiovascular Research Program Highlighted in 17 Presentations at the American Heart Association Scientific Sessions 2015

      The EXPLORER program is unmatched by any non-vitamin K oral anticoagulant (NOAC) in its size, scope and ambition and continues to generate important clinical evidence on XARELTO® (rivaroxaban)
      Learn more
      Corporate
      October 20, 2015

      Head Janssen Neuroscientist Appointed to Scientific Advisory Board of Global Dementia Discovery Fund

      Johnson & Johnson’s $10 Million Investment Supports U.K. Government-led Fund That Brings Together Industry, Government and Nonprofit Organizations in Pursuit of Novel Therapies
      Learn more
      Corporate
      October 15, 2015

      Johnson & Johnson Family of Consumer Companies Celebrates Spirit Day by Going Purple

      Learn more
      Corporate
      September 25, 2015

      Janssen’s daratumumab accepted for accelerated CHMP assessment for treatment of European patients with heavily pre-treated multiple myeloma

      Learn more
      Load more